3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Dystonic Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boesch, SM; Donnemiller, E; Müller, J; Poewe, W; Seppi, K; Weirich-Schwaiger, H; Wenning, GK | 1 |
| Berger, HJ; Cools, AR; Horstink, CA; Horstink, MW; Oyen, WJ; van der Werf, SP | 1 |
1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Dystonic Disorders
| Article | Year |
|---|---|
Writer's cramp: restoration of striatal D2-binding after successful biofeedback-based sensorimotor training.
Topics: Adult; Benzamides; Biofeedback, Psychology; Corpus Striatum; Dopamine Antagonists; Dystonic Disorders; Electromyography; Handwriting; Humans; Male; Middle Aged; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 2007 |
1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Dystonic Disorders
| Article | Year |
|---|---|
Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study.
Topics: Adult; Basal Ganglia; Benzamides; Cerebellum; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dystonic Disorders; Female; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Parkinsonian Disorders; Pyrrolidines; Receptors, Dopamine D2; Reference Values; Spinocerebellar Ataxias; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon | 2004 |